Post-translational modification-governed immune states in cancer immunity: Biomarker implications for checkpoint competence, tumor visibility and immunotherapy resistance (Review)
Aug 2026· International Journal of Oncology· Vol 69· 1 citation· 248 references
Medicine
TL;DR
By organizing PTM biology around measurable state variables rather than modification class alone, the present review provides a phase-aware translational framework for candidate biomarker discovery, fit-for-purpose validation, constraint-guided stratification, and therapeutic prioritization in cancer immunotherapy.
Abstract
Immune escape and therapeutic resistance remain major obstacles to durable benefit from cancer immunotherapy, yet transcript-based or abundance-based biomarkers often fail to capture the regulatory states that determine effective immune control. Post-translational modifications (PTMs) form a dynamic protein-state layer that rapidly reshapes protein stability, trafficking, complex assembly, and signaling persistence under tumor-intrinsic and therapy-imposed stress. In the present review, a biomarker-oriented framework is proposed in which PTM biology is interpreted through three recurrent immune constraints: Checkpoint competence, tumor visibility and stress-conditioned immune-state programming. Within this framework, programmed death-ligand 1 is viewed as a protein-state biomarker problem rather than a static expression marker; tumor visibility is defined by durable antigen-presentation competence and interferon-linked reinforcement; and stress-driven immune dysfunction is interpreted through metabolite-sensitive PTM rewiring and chromatin-coupled suppressive stabilization. Rather than cataloguing PTMs comprehensively in cancer immunity, the present review focuses on five core exemplar PTM axes, glycosylation, palmitoylation, ubiquitin editing, phosphorylation and lactylation, because they repeatedly map to rate-limiting immune constraints, are supported by mechanistic evidence, and represent candidate assay-compatible or intervention-relevant state variables at differing levels of translational maturity. It is further outlined how integrated proteogenomic, immuno-peptidomic, and spatial datasets can be used to discover candidate PTM-state biomarkers, validate mechanism-proximal readouts in prespecified pretreatment and on-treatment settings, and prioritize single or co-dominant state constraints for patient stratification, pharmacodynamic monitoring, and rational combination design. By organizing PTM biology around measurable state variables rather than modification class alone, the present review provides a phase-aware translational framework for candidate biomarker discovery, fit-for-purpose validation, constraint-guided stratification, and therapeutic prioritization in cancer immunotherapy.
Cancer immunotherapy has improved outcomes across many tumor types, but primary and acquired resistance, tumor heterogeneity and a shortage of safe targets remain unresolved. Part of this gap arises because tumor cells evade immune recognition not only through genomic mutation but also through post-transcriptional mRNA...
Y. Yukselten, Haseeb Ahmad, Mohammed Shoultout et al.· Frontiers in Immunology· 0 citations
Colorectal cancer (CRC) remains a major cause of cancer morbidity and mortality. Immune checkpoint inhibitors (ICIs) have transformed the treatment of microsatellite instability-high/mismatch repair-deficient (MSI-H/dMMR) CRC, yet most CRCs are microsatellite-stable/mismatch repair-proficient (MSS/pMMR) and remain poor...
Jin Yan, Rui-Xia Ma, Ya-Guang Xi· Genes· 0 citations
Radiotherapy can convert local tumor injury into systemic antitumor immunity, but this effect depends less on the nominal mode of cell death than on the tissue state that follows irradiation. This narrative review reframes radiation-induced regulated cell death around four functional outputs: antigen preservation, prod...
Xiao-Dong Wang, Wei Gao, Qian-Qian Wang et al.· Cancer Letters· 0 citations
A context-dependent state-transition model is proposed in which pressures are decoded by interconnected nutrient- and stress-sensing pathways, integrated through mitochondrial bioenergetic and redox adaptation, and translated by metabolite-dependent chromatin remodeling into persistent TAM functional programs that cons...
Jing-Hao Pan, Bo-Yang Li, Lucy Yue Lau et al.· Biochimica et biophysica act...· 0 citations
This review integrates the major tumor-intrinsic and tumor-extrinsic mechanisms that drive ICI resistance, including defective antigen presentation, impaired interferon signaling, oncogenic and epigenetic immune escape programs, metabolic rewiring, suppressive myeloid and stromal circuits, abnormal vasculature, and pro...
R. Karataş, Yaren Alras, Sarenur Teki̇ner et al.· Immunologic research· 0 citations
It is proposed that integrating precise editing, in vivo screening, single-cell multi-omics, and emerging artificial intelligence (AI)-assisted design may provide information and a design basis for future combined strategies that simultaneously target vulnerabilities in senescent cells and malignant populations.
Bo Fan, Aiwei Wu, Xue Pan et al.· Ageing and Cancer Research &...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.